A detailed history of Veriti Management LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Veriti Management LLC holds 53,035 shares of TAK stock, worth $691,046. This represents 0.06% of its overall portfolio holdings.

Number of Shares
53,035
Previous 65,726 19.31%
Holding current value
$691,046
Previous $937,000 21.45%
% of portfolio
0.06%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$13.89 - $15.04 $176,277 - $190,872
-12,691 Reduced 19.31%
53,035 $736,000
Q4 2023

Feb 05, 2024

SELL
$13.36 - $15.43 $71,235 - $82,272
-5,332 Reduced 7.5%
65,726 $937,000
Q3 2023

Oct 27, 2023

BUY
$15.03 - $16.32 $194,533 - $211,229
12,943 Added 22.27%
71,058 $1.1 Million
Q2 2023

Jul 13, 2023

SELL
$15.57 - $17.11 $42,490 - $46,693
-2,729 Reduced 4.49%
58,115 $912,000
Q1 2023

Apr 26, 2023

BUY
$15.28 - $16.48 $7,059 - $7,613
462 Added 0.77%
60,844 $1 Million
Q4 2022

Jan 20, 2023

SELL
$12.42 - $15.62 $38,464 - $48,375
-3,097 Reduced 4.88%
60,382 $0
Q3 2022

Oct 26, 2022

BUY
$12.8 - $28.65 $314,368 - $703,644
24,560 Added 63.11%
63,479 $823,000
Q2 2022

Jul 18, 2022

BUY
$13.12 - $15.03 $149,764 - $171,567
11,415 Added 41.5%
38,919 $546,000
Q1 2022

Apr 11, 2022

BUY
$13.54 - $15.35 $372,404 - $422,186
27,504 New
27,504 $394,000
Q4 2021

Jan 19, 2022

SELL
$13.17 - $16.4 $287,659 - $358,208
-21,842 Closed
0 $0
Q3 2021

Oct 08, 2021

BUY
$16.3 - $17.26 $12,518 - $13,255
768 Added 3.64%
21,842 $358,000
Q2 2021

Jul 13, 2021

BUY
$16.55 - $18.64 $177,018 - $199,373
10,696 Added 103.06%
21,074 $355,000
Q1 2021

Apr 14, 2021

BUY
$16.71 - $19.9 $21,823 - $25,989
1,306 Added 14.4%
10,378 $190,000
Q4 2020

Feb 11, 2021

BUY
$15.39 - $18.97 $139,618 - $172,095
9,072 New
9,072 $165,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $40.5B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Veriti Management LLC Portfolio

Follow Veriti Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.